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Summary
Bipolar affective disorder (BAD) affects ∼1%of the pop-
ulation and shows strong heritability. To identify po-
tential BAD susceptibility loci, we undertook a 15-cM
genome screen, using 214 microsatellite markers on the
35 most informative individuals of a large, statistically
powerful pedigree. Data were analyzed by parametric
two-point linkage methods under several diagnostic
models. LOD scores 11.00 were obtained for 21 mark-
ers, with four of these 12.00 for at least one model. The
remaining 52 individuals in the family were genotyped
with these four markers, and LOD scores remained pos-
itive for three markers. A more intensive screen was un-
dertaken in these regions, with the most positive results
being obtained for chromosome 4q35. Using a dominant
model of inheritance with 90% maximum age-specific
penetrance and including bipolar I, II, schizoaffective/
mania, and unipolar individuals as affected, we obtained
a maximum two-point LOD score of 2.20 (v  .15) at
D4S1652 and a maximum three-point LOD score of
3.19 between D4S408 and D4S2924. Nonparametric
analyses further supported the presence of a locus on
chromosome 4q35. A maximum score of 2.62 (P 
) was obtained between D4S1652 and D4S171 by.01
use of the GENEHUNTER program, and a maximum
score of 3.57 ( ) was obtained at D4S2924 us-P  .0002
ing the affected pedigree member method. Analysis of a
further 10 pedigrees suggests the presence of this locus
in at least one additional family, indicating a possible
predisposing locus and not a pedigree-specific mutation.
Our results suggest the presence of a novel BAD sus-
ceptibility locus on chromosome 4q35.
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Introduction
Bipolar affective disorder (BAD [MIM 125480]) is a
major psychiatric condition characterized by severe dis-
turbances of mood. The disorder has a variable age at
onset, with the initial presentation of illness typically
occurring during the 2d–4th decade, and is characterized
by episodes of mania and depression. BAD affects
1%–2% of the population and occurs both in families
and sporadically (MacKinnon et al. 1997). Twin, family,
and adoption studies indicate that BAD has a strong
genetic basis; however, the number of genes involved and
the mode of transmission of the disorder are poorly un-
derstood (Kelsoe 1997). Craddock et al. (1995) suggest
that a multiplicative model involving three or more loci
is necessary, to explain the heritability of BAD.However,
evidence indicating that a single major locus is respon-
sible for BAD has also been reported (Spence et al. 1995).
Many groups are currently investigating the genetic basis
of BAD, with interest focused on both identification and
confirmation of susceptibility loci on various chromo-
somes. However, to date, no specificmutations or genetic
polymorphisms have been identified that predispose to
the disorder.
Straub et al. (1994) reported a pedigree in which link-
age to BAD and the PFKL locus, situated on chromo-
some 21q22.3, was observed. Subsequent reports have
tended to support the view that a BAD susceptibility
locus exists on chromosome 21q22.2 (Gurling et al.
1995; Detera-Wadleigh et al. 1996; Smyth et al. 1997;
J. B. J. Kwok, L. J. Adams, J. A. Donald, P. B. Mitchell,
and P. R. Schofield, unpublished data), although some
groups have not found any evidence for this linkage
(Byerley et al. 1995). Linkage to markers in the peri-
centromeric region of chromosome 18 was identified by
Berrettini et al. (1994); this was supported by the results
of Stine et al. (1995), but was not supported by all stud-
ies (Maier et al. 1995; Pauls et al. 1995; Claes et al.
1997). In addition, linkage to markers on the long arm
of chromosome 18, but not the pericentromeric region,
has been reported (Stine et al. 1995; Coon et al. 1996;
De Bruyn et al. 1996; Freimer et al. 1996). The study
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Figure 1 Family 01 structure. Individuals marked with an asterisk (*) were genotyped in the initial genome screen. Blackened symbols
represent affected individuals, symbols with thick borders represent individuals typed in the follow-up screen, and symbols with fine borders
represent individuals not typed in the study. Sex of the individuals has been disguised to provide anonymity.
by Stine et al. (1995) also suggested the possibility of a
parent-of-origin effect in BAD. The results of several
whole-genome screens have added new dimensions to
the search for BAD susceptibility loci, with putative loci
reported on chromosomes 4p (Blackwood et al. 1996),
18q (Freimer et al. 1996), and 6p, 13q, and 15q (Ginns
et al. 1996). With predisposing loci having now been
described on chromosomes 4p, 6p, 13q, 15q, 18p, 18q,
21q, as well as on Xq (Baron et al. 1993; Pekkarinen et
al. 1996 [MIM 309200]), the evidence in favor of the
existence of multiple BAD susceptibility loci is becoming
increasingly strong.
We sought to identify BAD susceptibility loci by un-
dertaking a genome screen of a large, informative ped-
igree, by use of microsatellite markers. Initially, we gen-
otyped the 35most informative members of the pedigree.
Results of two-point linkage analysis on the data di-
rected us to regions that were then investigated in the
entire family (a further 52 individuals). Analysis of the
most positive markers for all 87 individuals of this family
resulted in one region (chromosome 4q35) that showed
significant LOD scores. Analyses of the chromosome
4q35 region in this family, and in other pedigrees in our
cohort, suggest that we have identified a novel suscep-
tibility locus for BAD.
Material and Methods
Families
The families that participated in this study came from
most states of Australia and were identified through a
survey of the Mood Disorders Unit, Prince Henry Hos-
pital, Sydney; the New South Wales Depression and
Mood Disorders Association; and publicity through ar-
ticles in popular magazines. These families were assessed
by means of the Diagnostic Interview for Genetic Studies
(Nurnberger et al. 1994), and best-estimate Research
Diagnostic Criteria diagnoses were made after indepen-
dent evaluation of all interviews and records. Individuals
whose DNAwas used in this study provided appropriate
informed consent. Medium- to large-sized multigener-
ational pedigrees that contained a minimum of three
affected individuals, at least two of whom were diag-
nosed with bipolar I, were recruited. The family used in
the initial genetic screen (fig. 1) contains 87 members
with available DNA samples, including 11 affected in-
dividuals: 5 bipolar I (BPI), 1 schizoaffective/mania (SZ/
MA), and 5 recurrent unipolar (UP;Mitchell et al. 1991).
The maximum and average expected LOD scores for
this family, as determined by SLINK (Ott 1989; Weeks
et al. 1990), are 8.64 and 3.95. Ten more pedigrees as-
certained in the same manner were typed for markers in
the most positive region identified from the genome
screen. These pedigrees consisted of 137 individuals for
genotyping, including 47 affecteds (22 BPI; 2 SZ/MA;
4 bipolar II [BPII]; and 19 UP). The pedigrees have com-
bined maximum and average expected LOD scores un-
der the assumption of homogeneity of 19.79 and 8.44,
respectively, and maximum and average lod scores under
the assumption of heterogeneity of 19.68 and 4.99, re-
spectively, as determined by SLINK.
Genotyping
DNA was extracted from whole blood by standard
techniques. Microsatellite markers analyzed were from
the Cooperative Human Linkage Centre (CHLC) da-
tabase and the Genome Database (GDB). Genotyping of
CHLC markers was performed by Research Genetics.
PCR of GDB markers was carried out in a 15-ml volume
containing 60 ng DNA; 375 mM dATP, dCTP, dGTP,
and dTTP; 5 mM each primer (the forward primer was
labeled with either 6-Fam or Tet fluorescent dye); 2.5
mM MgCl2, 1/10 volume of 10 # PCR buffer II (PE
Applied Biosystems) and 0.6 units AmpliTaq Gold poly-
merase (PE Applied Biosystems). Samples were amplified
on a Hybaid OmniGene thermal cycler, with the heated
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lid. The following profile was used for DNA amplifi-
cation: 95C for 12 min; 10 cycles of 15 s at 94C, 15
s at 55C, and 30 s at 72C; 20 cycles of 15 s at 89C,
15 s at 55C, and 30 s at 72C; 30 min at 72C; and
30 min at 35C. Samples were diluted 1/10 in dH2O,
and 1.5 ml was added to the dye-loading mix (2.5 ml
formamide, 0.5 ml blue dextran [50 mM EDTA, 50 mg/
ml blue dextran], 0.5 ml GS500 Tamra size standard [PE
Applied Biosystems]). One and five-tenths microliters of
each sample was loaded onto a 4% denaturing poly-
acrylamide gel and electrophoresed on ABI377 sequenc-
ers. Products were detected by means of the Genescan
program, version 2.0.2 (PE Applied Biosystems), and
alleles were assigned by the Genotyper program, version
1.1.1 (PE Applied Biosystems). All genotyping was car-
ried out by individuals blind to clinical diagnosis.
Chromosome 4q35 markers used and the distance be-
tween them as obtained from http://cedar.
genetics.soton.ac.uk/pub/chrom4/gmap in the direction
from centromere to q terminus were: D4S2417–9.2
cM–D4S2951–4.3 cM–D4S3041–3.1 cM–D4S1554–
0.4 cM-D4S2920–4.4 cM–D4S2954–3.4 cM–
D4S1535–1.0 cM–D4S408–4.7 cM–D4S2924–2.5
cM–D4S171–0.04 cM–D4S3051–0.4 cM–D4S3032–
0.04 cM–D4S426–1.7 cM–D4S2930–0.003 cM–
D4S1652. D4S1652 is the most distally reported poly-
morphic microsatellite marker on 4q.
Statistical Analysis
Two-point LOD scores were calculated between each
marker and the disease by use of the MLINK program
of the LINKAGE package, version 5.2 (Lathrop et al.
1984). Two disease thresholds were analyzed: Model I
considered all BPI, BPII, and SZ/MA individuals as af-
fected, and all other family members were considered
unaffected. Model II considered all affected individuals
from model I and all UP individuals as affected and all
other family members as unaffected.
Two penetrance groups with maximum age-specific
penetrance levels of either 60% or 90% and each con-
taining four liability classes (class 1, !20 years; class 2,
20–29 years; class 3, 30–39 years; and class 4,≥40 years)
were used. Liability classes in the 90% penetrance group
were defined with penetrances of 0.18, 0.45, 0.68, and
0.90; those in the 60% group were defined with pene-
trances of 0.12, 0.30, 0.45, and 0.60. Both dominant
and recessive models were analyzed, with a disease allele
frequency of .035 for the dominant model and .20 for
the recessive model. Data were also analyzed with the
dominant model and disease allele frequencies of .10 and
.20. Multi-point analysis was undertaken for the 15
markers studied on chromosome 4q35 by use of the
LINKMAP program of the LINKAGE package. The di-
agnostic models and penetrance groups used were the
same as for two-point analysis. The HOMOG program
(Ott 1991) was used to test for evidence of heterogeneity.
We have also used three nonparametric methods of
analysis that are more suited to the larger-sized pedigrees
found in our cohort. These nonparametric analyses in-
cluded the GENEHUNTER (Kruglyak et al. 1995),
MFLINK (Curtis and Sham 1995), and APM (Weeks
and Lange 1988) programs. We have not presented non-
parametric sib pair analyses (as has been typically done
by other groups with smaller or nuclear pedigrees), since
the small number of independent sib pairs in our pedi-




The 35 most informative individuals from family 01
(fig. 1) were subjected to an ∼15-cM genome screen by
use of 202 markers from the Weber (CHLC) 6 and 6a
panels of microsatellite markers. Chromosome 16 was
not genotyped, since each of these individuals had pre-
viously been genotyped for 12 microsatellite markers
(Adams et al. 1997). These 35 individuals were chosen
from the entire pedigree for this initial screen, since they
provided sufficient power to detect linkage, the maxi-
mum LOD score being 6.43, as determined by SLINK
(Ott 1989; Weeks et al. 1990). All data were analyzed
by means of the MLINK program of the LINKAGE
package. Disease models I (narrow definition, in which
only BPI, BPII, and SZ/MA were classified as affected)
and II (broad definition, in which BPI, BPII, SZ/MA, and
UP were classified as affected) were analyzed with both
dominant and recessive inheritance models and both
60% and 90% maximum age-specific penetrance levels.
Under SLINK simulations, no markers from a 214-
marker genome screen for a given genetic and diagnostic
model were expected to give a LOD score 13.00 by
chance, and less than one marker was expected to give
a LOD score 12.00 by chance. Two-point LOD scores
11.00 were obtained for 21 of the analyzed markers for
at least one diagnostic model, and four of these gave
scores 12.00. The four markers that gave LOD scores
12.00 were D1S518 ( ; model I, 90% dom-LOD  2.42
inant), D4S1652 ( ; model II, 90% domi-LOD  2.39
nant), D5S807 ( ; model II, 90% dominant),LOD  2.12
and D5S1470 ( ; model II, 90% dominant),LOD  2.92
and each was then analyzed in more detail.
The 52 additional individuals in family 01 for whom
DNA samples are available were typed for the four
markers that gave LOD scores 12.00, and two-point
analysis of the entire family was undertaken. The LOD
score for D1S518 was reduced from 2.42 to 0.20, thus
eliminating chromosome 1 from further analysis. LOD
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Table 1
LOD Scores for the Entire 87-Member Pedigree
for Chromosome 5Q Markers
DOMINANT RECESSIVE
MARKER 90% 60% 90% 60%
D5S392 10.34 1.28 3.65 .57
D5S1492 1.00 .80 .79 .72
D5S2505 .33 .61 .74 .60
D5S807 1.10 .73 .89 .70
D5S817 2.25 .19 .11 .05
D5S1473 .66 .17 .29 .16
D5S819 .47 .12 .47 .18
D5S1470 1.03 .41 .43 .42
D5S2494 1.94 .12 .23 .17
NOTE.— Linkage analysis was performed under
affection status model II.
Table 2
Two-Point LOD Scores for Family 1 for Chromosome 4Q35 Markers Under Model I (Narrow Disease Definition) and






RECOMBINATION FRACTION AT v 
.00 .05 .10 .15 .20
90% 60% 90% 60% 90% 60% 90% 60% 90% 60%
Model 1:
D4S2417 3.89 2.18 2.08 1.18 1.33 .76 .86 .49 .55 .31
D4S2951 2.54 1.35 .91 .24 .28 .12 .07 .27 .25 .33
D4S3041 .22 .03 .19 .00 .15 .03 .11 .05 .07 .06
D4S1554 3.45 1.12 1.45 .45 .77 .20 .41 .07 .20 .01
D4S2920 .54 .48 .51 .42 .46 .36 .41 .29 .34 .23
D4S2954 1.54 1.26 .72 .74 .46 .53 .32 .39 .23 .29
D4S1535 1.19 .73 .36 .25 .11 .08 .01 .01 .07 .02
D4S408 3.66 1.30 1.50 .57 .81 .28 .44 .14 .22 .06
D4S2924 .31 .30 .30 .26 .29 .22 .26 .17 .21 .12
D4S171 6.12 1.69 2.75 .91 1.65 .55 1.02 .34 .61 .21
D4S3051 .26 .18 .26 .15 .25 .12 .21 .08 .15 .05
D4S3032 .08 .13 .08 .11 .08 .08 .08 .06 .06 .04
D4S426 .29 .24 .28 .21 .27 .18 .24 .14 .20 .10
D4S2930 6.51 1.87 3.00 1.08 1.78 .68 1.09 .44 .66 .28
D4S1652 6.50 1.93 2.60 1.05 1.43 .63 .80 .37 .42 .22
Model 2:
D4S2417 6.30 2.18 3.06 1.68 1.96 1.17 1.29 .80 .83 .53
D4S2951 6.72 3.97 4.40 2.60 2.98 1.93 2.04 1.42 1.37 .99
D4S3041 1.15 .65 .93 .57 .76 .49 .60 .40 .47 .31
D4S1554 2.91 2.04 1.02 .77 .29 .26 .11 .01 .32 .14
D4S2920 1.64 .97 1.30 .78 1.03 .64 .81 .51 .63 .41
D4S2954 2.67 1.89 1.46 1.32 .99 .92 .69 .63 .46 .41
D4S1535 .19 .40 .73 .18 .98 .39 1.06 .47 1.04 .47
D4S408 .39 .04 1.27 .87 1.66 1.13 1.75 1.17 1.67 1.10
D4S2924 .67 1.29 1.00 1.23 1.04 1.13 .99 1.01 .88 .86
D4S171 .86 .74 1.34 1.38 1.87 1.55 2.03 1.56 1.98 1.45
D4S3051 .92 1.45 1.22 1.35 1.22 1.23 1.14 1.09 1.00 .92
D4S3032 .43 .49 .22 .33 .10 .22 .02 .14 .02 .09
D4S426 .60 1.24 .93 1.18 .98 1.09 .94 .97 .84 .83
D4S2930 1.57 .51 .63 1.15 1.28 1.34 1.53 1.37 1.57 1.28
D4S1652 .02 1.68 1.76 2.02 2.15 2.02 2.20 1.89 2.07 1.69
NOTE.—LOD scores 11.00 are underlined.
scores for the two chromosome 5 markers, D5S807 and
D5S1470, located ∼31 cM apart, remained 11.00 (table
1). A further seven markers on chromosome 5p were
analyzed, one of which, D5S1492, gave a LOD score of
1.00 (table 1).
A Potential Susceptibility Locus at 4q35
The chromosome 4q35 marker D4S1652 was the only
one with a LOD score that remained 12.00 after typing
of the entire family. A maximum LOD score of 2.20 was
obtained at recombination fraction (v) of 0.20 for model
II, with a dominant mode of inheritance and 90% max-
imum age-specific penetrance. Genotypes of the 87 ped-
igree members were obtained for a further 14 micro-
satellite markers spanning ∼35 cM of the distal arm of
chromosome 4q. Two-point analysis of the data revealed
seven markers in an ∼10-cM interval to have LOD scores
11.00 (table 2), with D4S1652 still having the largest
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Table 3
Variation in LOD Scores with Changes in Model Parameters
Variable D4S1652 D4S171 D4S2924 D4S408
Normala 2.20 2.03 1.04 1.75
Phenocopy 1% 2.16 2.07 1.00 1.77
Phenocopy 10% 1.15 1.48 .21 1.42
Disease
frequency 10% 2.21 2.03 1.04 1.75
Disease fre-
quency 20% 2.22 2.05 1.04 1.74
Maximum
penetrance
30% 1.53 1.03 1.30 .56
Maximum pene-
trance 12% 1.00 .61 1.02 .25
a Normal  90% maximum penetrance; 3.5% disease allele fre-
quency; and 0.5% phenocopy rate.
Figure 2 Three-point LOD scores of the 15 markers analyzed at 4q35 using model II with 90% (solid line) and 60% (dotted line)
maximum age-specific penetrance levels.
two-point score. To ascertain the robustness of these
linkage results, marked changes were made to a number
of model parameters, including disease allele frequency,
penetrance level, and phenocopy rate, to determine how
they affected the maximum LOD scores. The LOD
scores for these markers were found to be relatively ro-
bust to these changes (table 3) with all values remaining
positive, supporting the presence of a susceptibility locus
at chromosome 4q35.
Further Analysis of the 4q35 Locus
Three-point linkage analysis between sequential pairs
of the fifteen 4q35 markers was undertaken with the
LINKMAP program of the LINKAGE package. A max-
imal score of 3.19 was obtained between D4S408 and
D4S2924 for model II with a dominant mode of inher-
itance and a maximum age-specific penetrance level of
90% (fig. 2). This score was also robust, since lowering
the maximum age-specific penetrance level to 60% still
resulted in a maximum score of 3.19 (fig. 2). Although
the lack of a clear genetic or diagnostic model results in
multiple hypothesis testing, the consistent positive re-
sults for both the two-point (table 3) and the three-point
linkage analyses indicate a greater level of confidence in
the data than if positive results were to be found in only
some of the models tested.
Nonparametric methods of analysis were also used to
examine the data. Further support was provided by the
GENEHUNTER program (Kruglyak et al. 1996). Fam-
ily 01 was too large for all 87 individuals to be analyzed
simultaneously, so it had to be abridged for GENE-
HUNTER to run. A maximum score of 2.62 ( )P  .01
was obtained in the region spanning D4S1652 and
D4S171. However, depending on the way in which the
pedigree was subdivided, the GENEHUNTER scores
ranged from a high score of 2.62 ( ) to a low ofP  .01
0.59 ( ). The APM program (Weeks and LangeP  .16
1988) also provided limited support for a locus at 4q35,
with scores of 3.57 ( ) for and 1.97P  .0002 f(q)  1
( ) for for D4S2924. SignificantP  .0245 f(q)  1 q
APM scores were not obtained for the other chromo-
some 4 loci. The MFLINK program (Curtis and Sham
1995) was also used to analyze the data. A positive, but
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nonsignificant, score of 1.43 was obtained between
D4S171 and D4S2924.
Support for the 4q35 Locus in Other Pedigrees
A further 10 pedigrees in our cohort were genotyped
for four microsatellite markers at chromosome 4q35
(D4S1652, D4S171, D4S2924, andD4S408). Two-point
linkage analysis of all 11 families, under the broad di-
agnostic model (model II) with dominant inheritance
and 90%maximum age-specific penetrance, gave amax-
imum score of 2.03 ( ) at D4S1652, indicatingv  .20
that, as a whole, the additional 10 pedigrees do not
provide additional support for—but also do not re-
fute—the observation of linkage to chromosome 4q35.
The LOD score for D4S171 was 1.46 ( ), whereasv  .25
scores for the other two markers were !1.00.
Of the additional pedigrees genotyped, family 11 gave
a LOD score of 1.07 for marker D4S1652, which was
100% of the maximum LOD score that was expected
from SLINK analysis, thus indicating that linkage was
possible in this family as well. LOD scores 10.80 were
also obtained for markers D4S171 and D4S408. To en-
able a preliminary disease haplotype to be constructed,
members of family 11 were genotyped for a further three
markers at 4q35 (D4S2930, D4S426, and D4S3032),
and positive LOD scores were obtained: D4S426, LOD
score of 1.08 ( ); D4S2930, LOD score of 0.61v  .00
( ); and D4S3032, LOD score of 0.14 ( ).v  .00 v  .20
Three-point analysis of family 11 with the sevenmarkers
resulted in a maximum LOD score of 1.16 between
D4S2930 and D4S1652.
Small positive results were obtained in two additional
families for the four markers (D4S1652, D4S171,
D4S408, and D4S2924), but none of these were statis-
tically significant or represented a major fraction of the
maximum possible LOD score when compared with the
results obtained from simulation analysis (data not
shown). Heterogeneity analysis with the HOMOG pro-
gram (Ott 1991) showed statistically significant evidence
for linkage of D4S1652 ( ) and D4S171 (P ! .05 P !
) to BAD but no statistically significant evidence for.01
heterogeneity.
Discussion
A genome screen of 214 microsatellite markers in a
large Australian BAD pedigree has led to the identifi-
cation of a novel BAD susceptibility locus on chromo-
some 4q35. Importantly, the positive LOD scores ob-
tained were robust to changes in the model, with strong
support for linkage even when a maximum age-specific
penetrance level of 60% was used in the analysis (max-
imum multipoint LOD score of 3.19 between D4S408
and D4S2924). Furthermore, increasing the disease allele
frequency to as high as 0.20, or the occurrence of phe-
nocopies to 0.10, still gave positive results at 4q35, thus
substantiating the robustness of this finding. Results of
the nonparametric analyses also provide support for this
linkage result.
The lack of a clear genetic model has resulted in some
degree of multiple hypothesis testing, which would tend
to inflate the genomewide level of significance of the 3.19
LOD score. Until our results are independently repli-
cated, one must also consider the possibility that they
are due solely to chance. However, the robustness of the
linkage results to variation in model parameters provides
some degree of confidence in our conclusions. The fact
that at least one other pedigree in our cohort may also
be linked suggests that the locus may be a general BAD
predisposition gene and not a family-specific mutation.
In addition, the construction of a disease haplotype
based on the results of those pedigrees that show evi-
dence for linkage will be an important step in the further
elucidation of the genetic etiology of BAD. Lander and
Kruglyak (1995) have proposed that the term “sugges-
tive” linkage be used to describe statistical evidence for
linkage that is likely to occur one time at random in a
genome screen. A LOD score of 2.20 is required to sup-
port such a conclusion, which has been obtained in the
two-point analysis of our data. Although our three-point
linkage analyses reveal LOD scores of 3.19, they fall just
short of the criteria necessary to claim “significant” link-
age. Definitive evidence in support of a bipolar suscep-
tibility locus in the 4q35 region will require independent
confirmation.
All of the most positive scores identified at 4q35 were
for markers within an ∼10-cM region, defining a rela-
tively small region for other researchers to investigate in
their pedigrees. Evidence for linkage to 4q35 was pri-
marily identified under the broad diagnostic model
(model II), which includes both BP and UP individuals
as affected. Maximal LOD scores have also been ob-
tained in other studies using this diagnostic classification
(Berrettini et al. 1994; Straub et al. 1994). The finding
of no statistically significant evidence for heterogeneity
by the HOMOG program is probably due to the rela-
tively small data set currently analyzed and the fact that,
except for family 01, the pedigrees used in this study are
too small to produce large LOD score values.
Many groups have now reported positive linkage find-
ings in the study of BAD (reviewed in Risch and Botstein
1996; Baron 1997; Kelsoe 1997; MacKinnon et al.
1997), yet the most notable feature of the results of these
genomewide scans is the lack of studies replicating pre-
viously reported susceptibility loci. One identifiable fea-
ture of these studies is that significant evidence for link-
age resulting from either parametric or nonparametric
analyses have frequently been obtained from one or a
few large pedigrees. For example, the original identifi-
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cation of loci on chromosomes 21q22 (Straub et al.
1994), 18p (Berrettini et al. 1994), 18q (Freimer et al.
1996), 4p16 (Blackwood et al. 1996), Xq26 (Pekkarinen
et al. 1995), and three separate loci on chromosomes
6p, 13q, and 15q in the Old Order Amish (Ginns et al.
1996) were all made using large, statistically powerful
pedigrees. Our identification of a susceptibility locus on
chromosome 4q35 from the genome screen of the large
Australian pedigree is consistent with this pattern of a
specific linkage being identified through the use of a
large, statistically powerful pedigree.
Assuming that our results, and those of other groups
that have identified linkage, are real and not due to
chance, how could one explain this observation? The
occurrence of pedigree-specificmutations seems unlikely.
Additionally, in our study, a second pedigree also showed
evidence for a locus on chromosome 4q35. For other
candidate susceptibility regions, there have been a num-
ber of attempted replication studies, and general support
has been reported for chromosomes 21q22, 18p, 18q,
and possibly the long arm of the X chromosome (re-
viewed in Baron 1997; Kelsoe 1997; MacKinnon et al.
1997). Clearly, each of these reports adds further sup-
port to the conclusion that BAD has a complex genetic
etiology. One possible explanation is that, within a large
pedigree where a single susceptibility locus of modest
effect is segregating and several other susceptibility loci
are substantially homozygous, one may observe signif-
icant, although modest, evidence for linkage for that
single locus. If multiple independent susceptibility loci
are segregating, or a number of smaller pedigrees are
used, linkage would be difficult to identify. This inter-
pretation could explain the difficulties that have been
seen in undertaking replication studies and the negative
results obtained from some genome screens of large ped-
igrees. It would also suggest that increasing cohort size,
and thus the number of informative meioses, will not
necessarily lead to an immediate refinement of the map
position of the candidate locus. It may therefore be nec-
essary to significantly increase pedigree cohorts above
the typical current study size of several hundred indi-
viduals before one is able to precisely map and identify
such loci.
Potential susceptibility genes within the region of in-
terest identified in this study and specific susceptibility
alleles remain to be identified. Although a number of
transcripts expressed in the brain map to this region, the
lack of an underlying biochemical or neuroanatomical
basis to the disorder hampers the prioritization and ex-
amination of positional candidate genes.
The consistent lack of replication of linkage results
reinforces the notion that BAD has a complex genetic
etiology (Risch and Botstein 1996; Baron 1997; Kelsoe
1997; MacKinnon et al. 1997). In isolation, our results
strongly suggest the presence of a novel BAD suscepti-
bility gene at 4q35, with linkage in two of our pedigrees
providing evidence for a possible general susceptibility
locus rather than a rare pedigree-specific mutation. Rep-
lication of linkage to this locus by other groups and the
eventual identification of the allelic variation that results
in the presence of this susceptibility locus may provide
a means by which the molecular basis of this severe
psychiatric disorder can be defined and understood.
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